Skip to main content
Top
Published in: European Journal of Nutrition 2/2016

01-03-2016 | Original Contribution

Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study

Authors: Faith I. Umoh, Ikuko Kato, Jianwei Ren, Phillip L. Wachowiak, Mack T. Ruffin IV, D. Kim Turgeon, Ananda Sen, Dean E. Brenner, Zora Djuric

Published in: European Journal of Nutrition | Issue 2/2016

Login to get access

Abstract

Purpose

Systemic exposures to intestinal bacteria may play a role in the etiology of the chronic, low-grade inflammation that is associated with western diets. Production of lipopolysaccharide-binding protein (LBP) is one biomarker of increased exposures to intestinal bacteria. This study evaluated whether changes in diet quality could affect serum LBP.

Methods

This was a randomized, controlled trial of Mediterranean and Healthy Eating diets over 6 months in 120 healthy subjects at increased risk of colon cancer. Blood samples obtained before and after intervention were analyzed for LBP, branched-chain fatty acids characteristic of intestinal bacteria, micronutrients and cytokines. Data were analyzed for changes in LBP over time and for predictors of LBP.

Results

Serum concentrations of branched-chain bacterial fatty acids declined significantly in both diet groups. However, there was no significant change in mean serum LBP concentrations with either diet intervention. In serum, LBP was positively associated with CRP and negatively associated with carotenoids both before and after intervention. After intervention, LBP was predicted positively by both CRP and bacterial fatty acid concentrations in serum, and negatively by serum carotenoids and the ω3/ω6 fatty acid ratio. This model accounted for 30 % of the inter-individual variation in serum LBP after intervention.

Conclusions

These results indicate that dietary intervention over 6 months was insufficient to alter serum LBP. The relationships with inflammation-related markers, however, indicate that anti-inflammatory strategies other than changes in diet quality, such as weight loss or improved fitness, may have more potential for reducing systemic markers of LPS exposures in well-nourished populations.
Literature
1.
go back to reference Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, Schumann RR (1998) LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 101(10):2065–2071CrossRef Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, Schumann RR (1998) LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 101(10):2065–2071CrossRef
2.
go back to reference Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108(5):801–809CrossRef Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108(5):801–809CrossRef
3.
go back to reference Moreno-Navarrete JM, Escote X, Ortega F, Serino M, Campbell M, Michalski MC, Laville M, Xifra G et al (2013) A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 56(11):2524–2537CrossRef Moreno-Navarrete JM, Escote X, Ortega F, Serino M, Campbell M, Michalski MC, Laville M, Xifra G et al (2013) A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 56(11):2524–2537CrossRef
4.
go back to reference Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA (1999) Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 163(5):2792–2798 Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA (1999) Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J Immunol 163(5):2792–2798
5.
go back to reference Cohen J (2000) The detection and interpretation of endotoxaemia. Intensive Care Med 26(Suppl 1):S51–S56CrossRef Cohen J (2000) The detection and interpretation of endotoxaemia. Intensive Care Med 26(Suppl 1):S51–S56CrossRef
6.
go back to reference Novitsky TJ (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 851:416–421CrossRef Novitsky TJ (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 851:416–421CrossRef
7.
go back to reference Schumann RR (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39(4):989–993CrossRef Schumann RR (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39(4):989–993CrossRef
8.
go back to reference Elsing C, Ernst S, Kayali N, Stremmel W, Harenberg S (2011) Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy. Infection 39(4):327–331CrossRef Elsing C, Ernst S, Kayali N, Stremmel W, Harenberg S (2011) Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy. Infection 39(4):327–331CrossRef
9.
go back to reference Szponar B, Krasnik L, Hryniewiecki T, Gamian A, Larsson L (2003) Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin Chem 49(7):1149–1153CrossRef Szponar B, Krasnik L, Hryniewiecki T, Gamian A, Larsson L (2003) Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin Chem 49(7):1149–1153CrossRef
10.
go back to reference Binding N, Jaschinski S, Werlich S, Bletz S, Witting U (2004) Quantification of bacterial lipopolysaccharides (endotoxin) by GC-MS determination of 3-hydroxy fatty acids. J Environ Monit 6(1):65–70CrossRef Binding N, Jaschinski S, Werlich S, Bletz S, Witting U (2004) Quantification of bacterial lipopolysaccharides (endotoxin) by GC-MS determination of 3-hydroxy fatty acids. J Environ Monit 6(1):65–70CrossRef
11.
go back to reference Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS ONE 8(1):e54600CrossRef Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS ONE 8(1):e54600CrossRef
12.
go back to reference Laugerette F, Alligier M, Bastard JP, Drai J, Chanseaume E, Lambert-Porcheron S, Laville M, Morio B, Vidal H, Michalski MC (2014) Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol Nutr Food Res 58(7):1513–1518CrossRef Laugerette F, Alligier M, Bastard JP, Drai J, Chanseaume E, Lambert-Porcheron S, Laville M, Morio B, Vidal H, Michalski MC (2014) Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol Nutr Food Res 58(7):1513–1518CrossRef
13.
go back to reference Pastor Rojo O, Lopez San Roman A, Albeniz Arbizu E, de la Hera Martinez A, Ripoll Sevillano E, Albillos Martinez A (2007) Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 13(3):269–277CrossRef Pastor Rojo O, Lopez San Roman A, Albeniz Arbizu E, de la Hera Martinez A, Ripoll Sevillano E, Albillos Martinez A (2007) Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 13(3):269–277CrossRef
14.
go back to reference Schafer C, Parlesak A, Schutt C, Bode JC, Bode C (2002) Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 37(1):81–86CrossRef Schafer C, Parlesak A, Schutt C, Bode JC, Bode C (2002) Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 37(1):81–86CrossRef
15.
go back to reference Moreno-Navarrete JM, Ortega FJ, Bassols J, Ricart W, Fernandez-Real JM (2009) Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 94(10):4036–4044CrossRef Moreno-Navarrete JM, Ortega FJ, Bassols J, Ricart W, Fernandez-Real JM (2009) Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 94(10):4036–4044CrossRef
16.
go back to reference Hassanali Z, Ametaj BN, Field CJ, Proctor SD, Vine DF (2010) Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR: LA-cp rat. Diabetes Obes Metab 12(2):139–147CrossRef Hassanali Z, Ametaj BN, Field CJ, Proctor SD, Vine DF (2010) Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR: LA-cp rat. Diabetes Obes Metab 12(2):139–147CrossRef
17.
go back to reference Laugerette F, Furet JP, Debard C, Daira P, Loizon E, Geloen A, Soulage CO, Simonet C et al (2012) Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am J Physiol Endocrinol Metab 302(3):E374–E386CrossRef Laugerette F, Furet JP, Debard C, Daira P, Loizon E, Geloen A, Soulage CO, Simonet C et al (2012) Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am J Physiol Endocrinol Metab 302(3):E374–E386CrossRef
18.
go back to reference Lee SY, Kim YS, Lim JY, Chang N, Kang MH, Oh SY, Lee HJ, Kim H, Kim Y (2014) Effects of plant-based Korean food extracts on lipopolysaccharide-stimulated production of inflammatory mediators in vitro. Nutr Res Pract 8(3):249–256CrossRef Lee SY, Kim YS, Lim JY, Chang N, Kang MH, Oh SY, Lee HJ, Kim H, Kim Y (2014) Effects of plant-based Korean food extracts on lipopolysaccharide-stimulated production of inflammatory mediators in vitro. Nutr Res Pract 8(3):249–256CrossRef
19.
go back to reference Tsuji PA, Stephenson KK, Wade KL, Liu H, Fahey JW (2013) Structure-activity analysis of flavonoids: direct and indirect antioxidant, and antiinflammatory potencies and toxicities. Nutr Cancer 65(7):1014–1025CrossRef Tsuji PA, Stephenson KK, Wade KL, Liu H, Fahey JW (2013) Structure-activity analysis of flavonoids: direct and indirect antioxidant, and antiinflammatory potencies and toxicities. Nutr Cancer 65(7):1014–1025CrossRef
20.
go back to reference Yeon JY, Kim HS, Sung MK (2012) Diets rich in fruits and vegetables suppress blood biomarkers of metabolic stress in overweight women. Prev Med 54(Suppl):S109–S115CrossRef Yeon JY, Kim HS, Sung MK (2012) Diets rich in fruits and vegetables suppress blood biomarkers of metabolic stress in overweight women. Prev Med 54(Suppl):S109–S115CrossRef
21.
go back to reference Janakiram NB, Rao CV (2014) The role of inflammation in colon cancer. Adv Exp Med Biol 816:25–52CrossRef Janakiram NB, Rao CV (2014) The role of inflammation in colon cancer. Adv Exp Med Biol 816:25–52CrossRef
22.
go back to reference Sidahmed E, Cornellier ML, Ren J, Askew LM, Li Y, Talaat N, Rapai MS, Ruffin MT et al (2014) Development of exchange lists for Mediterranean and healthy eating diets: implementation in an intervention trial. J Hum Nutr Diet 27(5):413–425CrossRef Sidahmed E, Cornellier ML, Ren J, Askew LM, Li Y, Talaat N, Rapai MS, Ruffin MT et al (2014) Development of exchange lists for Mediterranean and healthy eating diets: implementation in an intervention trial. J Hum Nutr Diet 27(5):413–425CrossRef
23.
go back to reference Sen A, Ren J, Ruffin MT, Turgeon DK, Brenner DE, Sidahmed E, Rapai ME, Cornellier ML, Djuric Z (2013) Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial. Cancer Prev Res (Phila) 6(6):558–565CrossRef Sen A, Ren J, Ruffin MT, Turgeon DK, Brenner DE, Sidahmed E, Rapai ME, Cornellier ML, Djuric Z (2013) Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial. Cancer Prev Res (Phila) 6(6):558–565CrossRef
24.
go back to reference Menendez JA, Lupu R, Colomer R (2005) Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev 14(3):263–270CrossRef Menendez JA, Lupu R, Colomer R (2005) Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev 14(3):263–270CrossRef
25.
go back to reference Brondz I, Olsen I, Haapasalo M, Van Winkelhoff AJ (1991) Multivariate analyses of fatty acid data from whole-cell methanolysates of Prevotella, Bacteroides and Porphyromonas spp. J Gen Microbiol 137(6):1445–1452CrossRef Brondz I, Olsen I, Haapasalo M, Van Winkelhoff AJ (1991) Multivariate analyses of fatty acid data from whole-cell methanolysates of Prevotella, Bacteroides and Porphyromonas spp. J Gen Microbiol 137(6):1445–1452CrossRef
26.
go back to reference Xiao S, Zhao L (2014) Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol 87(2):303–314CrossRef Xiao S, Zhao L (2014) Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol 87(2):303–314CrossRef
27.
go back to reference Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Fruhbeck G, Burcelin R, Fernandez-Real JM (2012) Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond) 36(11):1442–1449CrossRef Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Fruhbeck G, Burcelin R, Fernandez-Real JM (2012) Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond) 36(11):1442–1449CrossRef
28.
go back to reference Sallam T, Ito A, Rong X, Kim J, van Stijn C, Chamberlain BT, Jung ME, Chao LC et al (2014) The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis. J Lipid Res 55(6):1120–1130CrossRef Sallam T, Ito A, Rong X, Kim J, van Stijn C, Chamberlain BT, Jung ME, Chao LC et al (2014) The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis. J Lipid Res 55(6):1120–1130CrossRef
29.
go back to reference Mariadason JM, Catto-Smith A, Gibson PR (1999) Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut 44(3):394–399CrossRef Mariadason JM, Catto-Smith A, Gibson PR (1999) Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut 44(3):394–399CrossRef
30.
go back to reference Oku H, Onotogi M, Nagata J, Wada K, Chinen I (1995) Selective use of l-valine and l-isoleucine for the biosynthesis of branched-chain fatty acids in rat skin. Biosci Biotechnol Biochem 59(5):891–895CrossRef Oku H, Onotogi M, Nagata J, Wada K, Chinen I (1995) Selective use of l-valine and l-isoleucine for the biosynthesis of branched-chain fatty acids in rat skin. Biosci Biotechnol Biochem 59(5):891–895CrossRef
31.
go back to reference Ran-Ressler RR, Sim D, O’Donnell-Megaro AM, Bauman DE, Barbano DM, Brenna JT (2011) Branched chain fatty acid content of United States retail cow’s milk and implications for dietary intake. Lipids 46(7):569–576CrossRef Ran-Ressler RR, Sim D, O’Donnell-Megaro AM, Bauman DE, Barbano DM, Brenna JT (2011) Branched chain fatty acid content of United States retail cow’s milk and implications for dietary intake. Lipids 46(7):569–576CrossRef
Metadata
Title
Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study
Authors
Faith I. Umoh
Ikuko Kato
Jianwei Ren
Phillip L. Wachowiak
Mack T. Ruffin IV
D. Kim Turgeon
Ananda Sen
Dean E. Brenner
Zora Djuric
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2016
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-0900-7

Other articles of this Issue 2/2016

European Journal of Nutrition 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.